ZanthoSyn®
Markets an astaxanthin dietary supplement for inflammatory health.
Cardax
Compiled from public sources
Unclaimed business
Unclaimed
- Claim to manage details & reply to reviews
- Pro profile & priority placement
- Reedleys Recognition & certificate
About Cardax
Based in Honolulu, Cardax is a consumer health company focused on marketing ZanthoSyn®, an astaxanthin dietary supplement for inflammatory health. ZanthoSyn® is sold through Cardax's commercial website. Cardax previously focused on developing pharmaceuticals for diseases driven by inflammation, including pre-clinical candidates CDX-101 for cardiovascular inflammation and dyslipidemia, and CDX-301 for macular degeneration. The company may seek to monetize these pharmaceutical assets through licensing or sale. Its current business centers on the supplement. Cardax describes ZanthoSyn® as physician recommended; product statements have not been evaluated by the FDA and the product is not intended to diagnose, treat, cure, or prevent disease.
Disclosure: Profile information has been compiled from publicly available sources and has not yet been verified by the business.
Representative photos. Illustrative images for this category, not photos of Cardax and not provided by the business.
Highlights
Commercial sales
ZanthoSyn® is available through Cardax's commercial website.
Pharmaceutical assets
May seek licensing or sale of pre-clinical drug candidates.
Cardax Reviews
No reviews yet — be the first to review Cardax.
Write a review
Sign in to write a review
or get a one-click link by email
No password needed. We only use your email to confirm the review is genuine.